1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D10B42942609BEB58525799200767F7C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/D10B42942609BEB58525799200767F7C!OpenDocument
18
19OpenDocument
203.94.202.88
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Clinical Operations » Clinical Trial Management

Report Summary: Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies to Ensure Medical Device Success in a Global Marketplace

ID: POP-238A


Pages: 4


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS

For report summary, click
Download FREE Excerpt on right

In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities. Emerging markets are also fast-growing regions that present future growth opportunities for organizations that have seen sales growth slow in mature markets.
However, there are still questions around the cost, acceptability, quality and pitfalls of conducting clinical trials in emerging regions.
Best Practices®, LLC conducted primary research to inform clinical affairs leaders at medical device companies on emerging approaches to staffing, outsourcing and managing clinical trials outside of the European and U.S. regions.

Critical outsourcing questions addressed in this survey include:

What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually from these regions?
Which clinical trial activities are best suited for outsourcing?
What is the appropriate staffing mix (in-house and outsourced) for clinical trials?
What are the most important competencies for clinical research associates, managers, and directors?

Industries Profiled:
Diagnostic; Medical Device; Health Care; Orthopaedics; Medical


Companies Profiled:
Abbott Vascular; Covidien; Medtronic; Medrad; Boston Scientific; Zimmer; BARD; St. Jude Medical; Smith & Nephew; Stryker; Teleflex

Study Snapshot

Research participants included 13 executives and managers from 11 medical device companies across a wide variety of therapeutic areas and product classes. In addition, four executive interviews were conducted to collect qualitative insights.

Key Findings

Seventy-one percent of the companies that participated in this study expect they’ll increase outsourced staffing during the next three years – and 86 percent believe the number of trials done in emerging markets will increase as well.

  • While the device segment split on the cost question, they were generally satisfied with the quality of outside-U.S. trials – 85 % rated quality with either medium or high satisfaction/success (15 % were low success).
Table of Contents

Executive Summary
Business Issue and Project Blueprint, p.5-7
Participants, p.8-9
Key Findings, p.10-14
Outside-U.S. Clinical Trial Overview and Insights, p.15-21
Clinical Affairs Budget and FTEs, p. 22-31
Clinical Affairs Presence Around the World, p.32-37
Cost and Quality of Outside-U.S. Trials and Outsourcing, p.38-45
Outsourcing Levels for Key Clinical Activities, p.46-55
Vendor Selection and Outsourcing Attributes, p.56-62
CRA, CRM, and CRD Competencies & Outsourcing Levels, p. 63-72
Clinical Affairs Organizational Fit, p.73-80
Outsourcing Success Factors and Pitfalls, p. 81-85
Trends and Directions for Outside-U.S. Trials & Outsourcing, p.86-88
Appendix, p. 89-94
About Best Practices, LLC, p.95